Literature DB >> 7593097

Preventing collapse in early osteonecrosis of the femoral head. A randomised clinical trial of core decompression.

K H Koo1, R Kim, G H Ko, H R Song, S T Jeong, S H Cho.   

Abstract

We performed a randomised trial on 37 hips (33 patients) with early-stage osteonecrosis (ON). After the initial clinical evaluation, including plain radiography and MRI, 18 hips were randomly assigned to a core-decompression group and 19 to a conservatively-treated group. All the patients were regularly followed up by clinical evaluation, plain radiography and MRI at intervals of three months. Hip pain was relieved in nine out of ten initially symptomatic hips in the core-decompression group but persisted in three out of four initially painful hips in the conservatively-treated group at the second assessment (p < 0.05). At a minimum follow-up of 24 months, 14 of the 18 core-decompressed hips (78%) and 15 of the 19 non-operated hips (79%) developed collapse of the femoral head. By survival analysis, there was no significant difference in the time to collapse between the two groups (log-rank test p = 0.79). Core decompression may be effective tin symptomatic relief, but is of no greater value than conservative management in preventing collapse in early osteonecrosis of the femoral head.

Entities:  

Mesh:

Year:  1995        PMID: 7593097

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  57 in total

1.  No differences in the efficacy among various core decompression modalities and non-operative treatment: a network meta-analysis.

Authors:  Byung-Ho Yoon; Young-Kyun Lee; Ki-Choul Kim; Yong-Chan Ha; Kyung-Hoi Koo
Journal:  Int Orthop       Date:  2018-05-31       Impact factor: 3.075

2.  Mid-term results of concentrated autologous bone marrow aspirate transplantation for corticosteroid-associated osteonecrosis of the femoral head in systemic lupus erythematosus.

Authors:  Yohei Tomaru; Tomokazu Yoshioka; Hisashi Sugaya; Yukiyo Shimizu; Katsuya Aoto; Hiroshi Wada; Hiroshi Akaogi; Masashi Yamazaki; Hajime Mishima
Journal:  Int Orthop       Date:  2018-04-28       Impact factor: 3.075

3.  A current review of core decompression in the treatment of osteonecrosis of the femoral head.

Authors:  Todd P Pierce; Julio J Jauregui; Randa K Elmallah; Carlos J Lavernia; Michael A Mont; James Nace
Journal:  Curr Rev Musculoskelet Med       Date:  2015-09

4.  Prediction of osteonecrosis collapse of the femoral head based on the proportion of the proximal sclerotic rim.

Authors:  Tong Yu; Limin Xie; Zhennan Zhang; Xun Ke; Yang Liu
Journal:  Int Orthop       Date:  2014-11-27       Impact factor: 3.075

5.  Comparison of core decompression and conservative treatment for avascular necrosis of femoral head at early stage: a meta-analysis.

Authors:  Yu-Cai Hong; Hui-Ming Zhong; Tiao Lin; Jian-Bin Shi
Journal:  Int J Clin Exp Med       Date:  2015-04-15

6.  CORR Insights®: Free Vascularized Fibular Grafting Improves Vascularity Compared With Core Decompression in Femoral Head Osteonecrosis: A Randomized Clinical Trial.

Authors:  Anton Plakseychuk
Journal:  Clin Orthop Relat Res       Date:  2017-06-22       Impact factor: 4.176

Review 7.  [Conservative treatment of atraumatic femoral head necrosis].

Authors:  U Maus; J Flechtenmacher; K M Peters
Journal:  Orthopade       Date:  2018-09       Impact factor: 1.087

8.  Heritable thrombophilia-hypofibrinolysis and osteonecrosis of the femoral head.

Authors:  Charles J Glueck; Richard A Freiberg; Ping Wang
Journal:  Clin Orthop Relat Res       Date:  2008-03-19       Impact factor: 4.176

Review 9.  The use of bisphosphonate in the treatment of avascular necrosis: a systematic review.

Authors:  Juliana Bahia Cardozo; Débora Motta S Andrade; Mittermayer B Santiago
Journal:  Clin Rheumatol       Date:  2008-02-13       Impact factor: 2.980

10.  Outcome after tantalum rod implantation for treatment of femoral head osteonecrosis: 26 hips followed for an average of 3 years.

Authors:  Sokratis E Varitimidis; Apostolos P Dimitroulias; Theophilos S Karachalios; Zoe H Dailiana; Konstantinos N Malizos
Journal:  Acta Orthop       Date:  2009-02       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.